The Effect of Nasal Continuous Positive Airway Pressure Treatment on PTSD Symptoms. (PTSD)
The Effect of Nasal Continuous Positive Airway Pressure (Nasal CPAP) Treatment on Post Traumatic Stress Disorder (PTSD) Symptoms.
研究概览
详细说明
Design: This is a pilot study to study the effect of nasal CPAP on the symptoms of PTSD in veterans.
Recruitment Methods:
Veterans with PTSD will be recruited from the Northport VAMC PTSD unit. The ACOS/Mental Health will refer patients that meet inclusion criteria and do not have an impaired decision making capacity. Subjects will be screened for decision-making capacity by their treating psychiatrist as part of their clinical assessment upon admission to the PTSD unit.
Study Methods
This will be a prospective, randomized, controlled interventional trial:
- Participants will undergo a routine clinical sleep study at the PTSD unit (using a portable polysomnographic recording unit). or undergo a routine clinical polysomnography to diagnose sleep disordered breathing
Participants who demonstrate SDB will be randomized into two groups based upon their body mass index
- Group A: BMI < 30 kg/m2
- Group B: BMI > 30 kg/m2 The reason for these two arms is to study the effect of nasal CPAP upon PTSD symptoms in veterans with a high prevalence of sleep apnea ( BMI above 30 kg/m2) and in veterans with predominantly snoring (BMI below 30 kg/m2).
Each group will then be randomized into two sub-groups regarding treatment.
- Treatment group receives an automated CPAP unit to use during sleep for 6 weeks in conjunction with their usual care in the PTSD unit (psychotherapy).
- Control group receives the usual care that is provided in the PTSD unit for 6 weeks (change in medications will exclude the subject from the study), if any participant in the control group would like to try nasal CPAP, then he will be crossed over to use an automated CPAP unit during sleep for his second 6 weeks in the PTSD unit together with usual care.
All participants will fill out the following questionnaires at baseline and after 6 weeks. (Those in the control group who have been crossed-over to nasal CPAP will also fill out a set of questionnaire at 12 weeks).
- PTSD checklist-military version (anxiety)
- MASQ anxious arousal subscale (anxiety)
- Insomnia Severity Index (insomnia)
- The alcohol craving questionnaire (with an alcohol history during the intake) The changes in patient's reported outcomes will be compared before and after CPAP treatment and psychotherapy alone
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
New York
-
Northport、New York、美国、11768
- PTSD unit at Northport VAMC
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
A. Admitted to PTSD unit at NVAMC and will remain in the unit for at least 12 weeks after initiation of study participation.
B. Found to have SDB by polysomnography
Exclusion Criteria:
- Impaired Decision-Making Capacity, as determined by treating psychiatrist.
- No sleep disordered breathing found by polysomnography
- Unable/unwilling to use the nasal CPAP
学习计划
研究是如何设计的?
设计细节
- 观测模型:案例交叉
- 时间观点:预期
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
The Effect of nasal Continuous Positive Airway Pressure (nasal CPAP) Treatment on Post Traumatic Stress Disorder (PTSD) Symptoms.
大体时间:six weeks of nasal CPAP
|
A comparison of the effectiveness of six weeks of nasal CPAP plus usual care to usual care alone at decreasing the symptoms of PTSD (anxiety, insomnia and alcohol craving) among veterans with PTSD and SDB
|
six weeks of nasal CPAP
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
The Effect of nasal Continuous Positive Airway Pressure (nasal CPAP) Treatment on Post Traumatic Stress Disorder (PTSD) Symptoms.
大体时间:6 weeks of nasal CPAP
|
A comparison of the change in symptoms to the change in the total of sleep stage shifts during sleep for all patients with PTSD and SDB participating in the study.
|
6 weeks of nasal CPAP
|
合作者和调查者
调查人员
- 首席研究员:Mohammad Amin, MD、Northport VAMC
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 00383
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.